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ABSTRACT
Background and objective: CD4+CD25+ regulatory T (Treg) cells
play an essential role in maintaining immune homeostasis. In
this study, we investigated whether the induced sputum (IS)
pool and the function of CD4+CD25+ Treg cells are altered in
asthma pediatric patients. 
Methods: Treg activity was studied in the IS of 40 asthmatic
children. CD3+ cells were analyzed for the expression of FoxP3
mRNA by real time reverse transcription–polymerase chain re-
action (RT–PCR). IS cells from asthmatics and controls were
stained for Treg markers and analyzed by flow cytometry. We al-
so studied the ability of Treg cells to differentiate monocytes
toward alternatively activated macrophages (AAM), and to
suppress proinflammatory cytokines. 
Results: (i) Mild and moderate asthmatics had significantly de-
creased expression of FoxP3/β-actin mRNA and decreased pro-
portions of CD4+CD25highFoxP3+ cells compared to healthy chil-
dren; (ii) patients with moderate asthma had even lower pro-
portions of FoxP3 expression compared to mild asthmatic pa-
tients; (iii) monocytes cultured with Treg cells displayed typical
features of AAM, including up-regulated expression of CD206
(macrophage mannose receptor) and CD163 (hemoglobin
scavenger receptor), and an increased production of chemokine
ligand 18 (CCL18). In addition, Treg cells from asthmatics have
a reduced capacity to suppress LPS-proinflammatory cytokine
production from monocytes/macrophages (IL-1, IL-6 and TNF-α). 
Conclusion: Asthma pediatric patients display a decreased
bronchial Treg population. The impaired bronchial Treg activity
is associated with disease severity. 
Keywords: Bronchial asthma, CD4+CD25highFoxP3+, induced
sputum, inflammatory cytokines, regulatory T cells.
RIASSUNTO
Finalità: Le cellule T regolatorie (Treg) CD4+CD25+ svolgono un
ruolo fondamentale nel mantenere l’omeostasi dell’immunità.
In questo studio si è ricercato se la quantità e la funzione delle
cellule Treg CD4+CD25+ risultino alterate nello sputo indotto
(IS) di pazienti asmatici in età pediatrica.
Metodi: L’attività dei Treg è stata studiata prendendo in esame
l’IS di 40 bambini asmatici. Le cellule CD3+ sono state analizza-
te per l’espressione di FoxP3 mRNA attraverso la retro trascri-
zione della reazione a catena della polimerasi (RT–PCR) in
tempo reale. Le cellule dell’IS di asmatici e soggetti di controllo
sono state colorate specificamente per i Treg marker e analizza-
te con la citometria a flusso. Si è studiata altresì la capacità
delle cellule Treg di differenziare i monociti in macrofagi alter-
nativamente attivati (AAM), e di sopprimere citochine proin-
fiammatorie.
Risultati: Risultati principali ottenuti: (i) Pazienti affetti da
asma lieve e moderato mostravano una considerevole riduzio-
ne dell’espressione di FoxP3/β-actin mRNA e una ridotta pro-
porzione di cellule CD4+CD25highFoxP3+ in confronto a bambini
sani; (ii) Pazienti affetti da asma moderato presentavano pro-
porzioni ancora più basse di espressione di FoxP3 rispetto ai
pazienti con asma lieve; (iii) Monociti coltivati con le cellule
Treg hanno mostrato i tratti caratteristici di AAM, comprese le
espressioni up-regolate di CD206 (recettore macrofagico per il
mannosio) e CD163 (recettore “scavenger” per l’emoglobina), e
un aumento della produzione di ligando 18 delle chemochine
(CCL18). 
Inoltre i Treg degli asmatici evidenziano una ridotta capacità di
sopprimere la produzione delle citochine LPS-proinfiammatorie
da monociti/macrofagi (IL-1, IL-6 e TNF-α).
Conclusioni: I pazienti pediatrici con asma presentano un
decremento della popolazione bronchiale di Treg. La compro-
+ Kamel Hamzaoui
Medicine University Tunis, 
15, Rue Djebel Lakdar, 1007 Tunis, Tunisia
email: kamel.hamzaoui@gmail.com
Data di arrivo del testo: 13/11/2009 – Accettato dopo revisione: 04/12/2009
Multidisciplinary Respiratory Medicine 2010; 5(1): 22-30
Original Article / Articolo Originale
Regulatory T cells in induced sputum 
of asthmatic children: association with
inflammatory cytokines
Cellule T regolatorie nello sputo indotto di bambini
asmatici: associazione con le citochine infiammatorie 
Agnès Hamzaoui1-2, Jamel Ammar1-2, Kamel Hamzaoui1
1Medicine Faculty, University of Tunis, Homeostasis and Cell Dysfunction (UR/99/08-40), Tunisia 
2Department of Respiratory Diseases, Pavillon B, A. Mami Hospital, Ariana, Tunisia












Treg cells in induced sputum
 of asthm
atics – Linfociti Treg nello sp
uto indotto di asm
atici
missione dell’attività bronchiale dei Treg è proporzionale al
livello di gravità della malattia.
Parole chiave: Asma bronchiale, CD4+CD25highFoxP3+, cellule
regolatorie T, citochine infiammatorie, sputo indotto.
INTRODUCTION
Chronic mucosal inflammation plays an essential
role in the pathogenesis of asthma. Pathological
pathways of asthma are observed early in child-
hood, bronchial inflammation being observed in
infants and remodelling in younger children [1,2].
Interactions between dendritic cells,
monocytes/macrophages and lymphocytes induce,
amplify or modulate the ongoing inflammation [3].
Recent studies have also investigated regulatory T
(Treg) cells in asthma [4,5], and it is possible that
the recruitment of Treg cells into the airways sup-
presses allergic airway inflammation [6]. A recent
study examining pediatric asthmatic patients found
a low percentage of CD4+CD25high T cells (Tregs) in
the bronchoalveolar lavage (BAL) compared to
healthy controls or children treated with corticos-
teroids [7]. Additional studies in animal models of
allergic airway inflammation have provided more
insight into the role of Tregs in asthma [6,8]. During
inflammation, the interactions between
CD4+CD25+ Treg cells and antigen presenting cells
(APC) are likely to involve not only dendritic cells
(DC) but also monocytes/macrophages which play
a critical role in both innate and adaptive immunity.
Indeed, these cells are able to recognize pathogens
and/or “danger signals” via Toll-like receptors
(TLRs) and other pattern-recognition receptors and
produce a wide array of cytokines and chemokines.
The initial inflammatory response is carried out by
macrophages that produce high amounts of proin-
flammatory cytokines. These macrophages with a
higher phagocytic capacity produce anti-inflamma-
tory cytokines and are characterized by an
increased expression of the mannose receptor
CD206 and/or the hemoglobin scavenger receptor
CD163. These cells are often referred to as M2 or
alternatively activated macrophages (AAM) [9-10].
Given the pivotal role of CD4+CD25+ Treg cells in
maintaining self-tolerance, we here investigated
whether the pool and the function of CD4+CD25+
Treg cells are altered in induced sputum from
bronchial asthma patients. Then, we assessed a pre-
viously uncharacterized function of CD4+CD25+
FoxP3+ Treg cells, namely their ability to directly




Subject characteristics are shown in Table I. Patients
were under consultation at the Department of
Respiratory Pediatrics of A. Mami Hospital. The
diagnosis of asthma was based on a history of
episodic wheezing and dyspnea. Asthma severity
was classified according to GINA (Global Initiative
for Asthma) criteria [11]. All patients from asthmatic
groups were atopic as defined by at least two posi-
tive skin prick tests to common allergens. Asthma
was classified as mild in twenty cases. These
patients had no regular treatment with inhaled
steroids. Eighteen other patients were suffering from
moderate persistent asthma. They were treated with
inhaled steroids (400–500 µg of beclomethasone
daily). At sampling time, a good control of asthma
was reached in all cases and the patients had no
evidence of respiratory infection. Subjects with a
history of respiratory infection during the previous
four weeks were excluded from the study. Blood
and induced sputum samples were collected from
subjects during their visits to the outpatient clinics.
Informed consent was obtained from all subjects'
parents or guardians, and approval was obtained
from our institutional review board.
Sputum induction and processing
Induced sputum was obtained as we recently
reported [12]. Before sputum induction all patients
inhaled salbutamol (200 µg) via a metered dose
inhaler. Baseline peak expiratory flow (PEF) was
measured and this was repeated following salbuta-
mol inhalation and after each 5-minute inhalation
of nebulized hypertonic saline. The procedure was
stopped if the PEF fell by > 10% following saline or
by > 20% at any time during the induction proce-
dure. Solid sputum material was separated from
saliva before processing as we have recently report-
ed [12]. Briefly, selected sputum was weighed and
0.1% dithiothreitol (DTT) (Sigma-Aldrich, Poole,
UK) in phosphate-buffered saline (PBS) was added
at a ratio of 4 ml to 1 g sputum. The sputum was
incubated with DTT at room temperature for 15
minutes on a rolling mixer. The same volume (4 ml
to 1 g sputum) of PBS was added to the sputum and
then filtered through 48 µm nylon gauze. 
The filtrate was centrifuged at 400 g (Sorvall
RT6000D, Kendro, Bishop’s Stortford, UK) for 10
minutes at 4°C to pellet cells. The cells were resus-
pended in PBS containing 0.1% bovine serum albu-
min (BSA). The viability of the sample was deter-
mined by trypan blue exclusion staining (Sigma-
Aldrich) in a Neubauer hemocytometer (Merck
Eurolabs, Lutterworth, UK). Induced sputum cells
were resuspended (2 x 105 cells/ml) in PBS and
cytospin slides were prepared (Shandon cytospin;
400 rpm, 5 min), stained (Shandon Diffquick), and
coded, and 500 cells were counted and expressed
as % of non squamous epithelial cells. Absolute
counts were generated from the differential and
total counts.
Cell isolation from peripheral blood
Peripheral blood was obtained from 10 patients
with moderate bronchial asthma (the same patients
studied for Treg cells induced sputum) and from 7
healthy children, following informed consent.
Peripheral blood mononuclear cells (PBMC) were





























0 isolated by using density gradient centrifugation
(Lymphocyte separation media, PAA Laboratories).
Monocytes (> 95% purity) were isolated by using
anti-CD14 microbeads or by depleting nonmono-
cytes (Miltenyi Biotec). CD4+ T cells (> 95% purity)
were purified by using a T cell isolation kit, and
CD4+CD25+ T cells were enriched with anti-CD25
microbeads (Miltenyi Biotec) resulting in > 90%
CD4+CD25+ T cells with > 87% expressing FoxP3+
cells. In addition, separation of CD4+CD25high and
CD4+CD25- T cells from total CD4+ T cells was per-
formed by using MoFlo®. For flow cytometry, the
following antibodies were used: anti-CD3-
fluorescein isothiocyanate (FITC), anti-CD4-
phycoerythrin (PE)-Cy5, anti-CD14- PE-Cy5, CD86-
PE, anti-CD25-FITC (all from Beckman-Coulter),
anti-CD206-PE, anti-CD25-PE (Miltenyi Biotec),
and CD163-FITC (Santa Cruz Biotechnology). 
Flow cytometry for Treg cells expression in induced
sputum
Further separation of CD3+ T cells (negative selection
by monodisperse), induced sputum (IS) cells were
stained with FITC-conjugated anti-CD4, PE-conju-
gated anti-FoxP3 and allophycocyanin (APC)-conju-
gated anti-CD25 antibodies with appropriate isotype
controls (all from eBiosciences, San Diego, CA,
USA). Flow cytometry was performed using a fluo-
rescence activated cell sorter (FACS) Calibur instru-
ment with CellQuest software (Becton Dickinson,
San Diego, CA, USA). List mode files were collected
for 200,000 cells from each sample. CD25high cells
were defined as described elsewhere [13-14]. 
PBMC co-cultures of T cells and monocytes
Monocytes and T cells (2:1 ratio) were co-cultured
in Roswell Park Memorial Institute (RPMI) medium
1640, supplemented with 1% penicillin/strepto-
mycin, 1% glutamin, and 10% heat-inactivated
FCS. Monocytes (5 × 105/ml) were cultured in
either 200- or 500-µl cultures without T cells
(monocytes), with CD4+CD25− T cells or
CD4+CD25+ T cells (CD25+) for 40 h in the pres-
ence of 50 ng/ml anti-CD3 mAb (OKT3, Ortho
Biotech), after which the different cultures were
stimulated for 24 h with Lipopolysaccharide (LPS)
50 ng/ml (Sigma); this was found to be the optimal
concentration out of a dose range (0–100 ng/ml) to
stimulate monocytes for interleukin (IL)-6 and
tumor necrosis factor (TNF)-α production. 
Detection of cytokines and chemokines
IL-6, TNF-α (Invitrogen), CCL18 (R & D Systems),
were measured by ELISA, and IL-1β, was measured
by Luminex (Upstate) by using a Luminex 100 sys-
tem, according to the manufacturer's instructions. 
Statistical analysis
Statistical analysis was performed with GraphPad
Prism 4.03 software by using Wilcoxon matched
paired tests or impaired t-test. P values < 0.05 were
considered significant. 
RESULTS
The proportion of Treg in induced sputum from
bronchial asthma 
As shown in Figure 1A, patients with bronchial
asthma (mild asthma and moderate asthma) had sig-
nificantly decreased gene expression of the tran-
scriptional factor FoxP3 in CD3+ cells compared to
healthy children (mean ± SD: 5.40 ± 1.70; range:
3.0 – 9.0). Significant differences were observed in
the FoxP3 expression between mild (2.61 ± 0.98;
range: 1.0 – 5.0) and moderate bronchial asthma
(1.16 ± 0.60; range: 0.3 – 2.0) (p = 0.0001). This
reduction of FoxP3 was extended and confirmed by
flow cytometry, showing decreased proportions of
CD4+CD25highFoxP3+ cells in the CD4+ cell popula-
tion of the mild (0.85 ± 0.48; range: 0.2 – 2.0) and
moderate (0.80 ± 0.39; range: 0.4 – 1.7) bronchial
asthma patients compared to healthy children (2.33
± 0.83; range: 0.98 – 3.9) (Figures 1B and 1C).
Values of CD4+CD25highFoxP3+ cells in the CD4+
cell population were also expressed in absolute
number [(mean ± SD) x106/mL]. The decreased
CD4+CD25highFoxP3+ cells in mild asthmatics
(0.047 ± 0.023) and in moderate asthmatics (0.044
± 0.021) were maintained when values were
expressed as absolute values compared to healthy
controls (0.13 ± 0.046). No significant differences
were observed between mild and moderate asth-
matics when values were expressed as absolute val-
ues.
Alternative activation in monocytes/macrophages
induced by Treg cells
A previously uncharacterized function of Treg cells,
namely their ability to steer monocyte differentia-
TABLE I: CLINICAL CHARACTERISTICS AND INDUCED SPUTUM CELL DISTRIBUTION OF CHILDREN WITH MODERATE AND
MILD ASTHMA AND CONTROLS
Subject group: Age: Sex Atopy Asthma Total IgE
n. cases median (range) F/M history (kU/L)
Control: 20 9.75 (6 – 15) 12/8 No No 65.7 ± 22.7
Mild asthma: 23 11.5 (5 – 16.5) 14/9 Yes 2.3 yrs (0–5 yrs) 296.7 ± 197†
Moderate asthma: 17 12 (5 – 16.5) 8/9 Yes 4.2 yrs (3–7 yrs) 385 ± 227
Age was expressed as median (range). 
Definition of abbreviations: F, female; M, male.
† p < 0.005 compared to healthy controls.
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tion toward alternatively activated macrophages
(AAM) has been recently depicted [10]. AAM are
cells with strong anti-inflammatory potential
involved in immune regulation, tissue remodeling,
and parasite killing. We investigated 10 healthy
controls and 7 moderate asthmatics.
To investigate whether CD4+CD25+ Treg cells from
patients with bronchial asthma can steer the differ-
entiation of monocytes to AAM, CD14+ monocytes
isolated from peripheral blood mononuclear cells
from moderate asthmatics were cultured alone,
with autologous CD4+CD25− or CD4+CD25+ T
cells. We used the same methodology reported by
Tiemessen et al. [10]. Anti-CD3 mAb was present in
all conditions to stimulate T cells. After 40 h, cells
were collected for flow cytometry. 
Figures 2A and 2B show that, relative to control
monocytes, Treg-treated monocytes displayed a
strong up-regulation of the typical AAM markers
CD206 (n = 15, p < 0.05) and CD163 (n = 7, 
p < 0.02).The increased expression of CD206 and
CD163 was greater in moderate asthmatics than in
healthy controls, when monocytes were co-cultured
with CD4+CD25+ (Figures 2A, 2B). We also deter-
mined the presence of CCL18, a chemokine that is
specifically overexpressed by AAM [15], and found
this to be significantly enhanced in monocyte/Treg
co-cultures in asthmatics when compared to
healthy controls (Figure 2C). 
CD4+CD25+ Tregs from moderate asthma did not
inhibit the proinflammatory response of monocytes/
macrophages to LPS 
Next we determined the ability of Treg-treated
monocytes/macrophages from moderate asthmatics













































































FIGURE 1: ANTIGEN EXPRESSION OF T CELLS IN HEALTHY CHILDREN AND PATIENTS WITH MILD AND MODERATE
BRONCHIAL ASTHMA
Expression of forkhead box P3 (FoxP3) mRNA in T cells (A) and proportions of CD4+CD25highFoxP3+ cells in the CD4+ cell population (B), among
healthy children and patients with mild and moderate bronchial asthma. Medians are indicated by a line inside each box, the 25th and 75th
percentiles by the box limits, the lower and upper error bars represent the 10th and 90th percentiles, respectively. (C): CD4+CD25high and
CD4+CD25high forkhead box P3 (FoxP3)+ cells in one representative moderate bronchial asthma children as measured by flow cytometry. Boxes
(a) indicate cells in the CD25high population. Quadrants (b) indicate CD25highversus CD25low/intermediate cells and FoxP3+versus FoxP3– cells.






























trols and 7 moderate asthmatics. As shown in Figures
3A, 3B and 3C monocytes cultured in the presence
of CD4+CD25− effector T cells displayed increased
production of proinflammatory cytokines. To
exclude possible contributions of T cell-derived
cytokines in these assays, we repeated these experi -
ments twice with monocytes that were repurified
after Treg co-culture and obtained similar results.
Following co-culture of monocytes from healthy
controls with autologous CD4+ CD25+ FoxP3+ Treg
cells, there was significant suppression in their
capacity to produce proinflammatory cytokines IL-
1β (Figure 3A), TNF-α (Figure 3B) and IL-6 (Figure
3C) compared to monocytes cultured alone. In
patients with moderate asthma, monocytes cultured
alone produced more IL-1β, TNF-α and IL-6 than
monocytes from healthy controls. Co-culture of
monocytes from moderate asthmatic CD4+ CD25+
FoxP3+ Treg cells failed to suppress TNF-α, IL-6 and
IL-1β  production.
Increased expression of Treg cells in induced 
sputum in patients with moderate asthma after
treatment with inhaled corticosteroid 
Eight patients with moderate asthma were investi-
























































































FIGURE 2: TREG CELLS INDUCTION OF AN ALTERNATIVE ACTIVATED PHENOTYPE IN MONOCYTES/MACROPHAGES OF
MODERATE ASTHMA CHILDREN AND CONTROLS 
Monocytes were cultured without T cells (monocytes), with CD4+CD25− T cells, or with CD4+CD25+ T cells in the presence of anti-CD3 mAb
(50 ng/ml). Moderate asthma = white bars; healthy controls = black bars. (A and B): The phenotype of monocytes was assessed after 40 h of
culture by flow cytometry. The expression (average mean fluorescence intensity, MFI ± SEM) of CD206 and CD163 is shown for ten indepen-
dent experiments, respectively. (C): The amount of CCL18 produced during the 40 h of co-culture was analyzed in the supernatant by ELISA.
Significant differences were observed between moderate asthmatic children and control healthy children. 
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treatment. 
They received a stepwise treatment after enroll-
ment, including inhaled corticosteroid (budes-
onide) and β2-agonists, as recommended by GINA
[11]. Six weeks later, the patients were revisited.
They were completely controlled regarding asth-
matic symptoms after treatment according to the
Asthma Control Test (www.asthmacontrol.com).
Induced sputum was collected again. Changes of
CD25highFoxP3+ cells in the CD4+ cell population
were measured and compared to values obtained
before the treatment. CD4+CD25high T cell percent-
ages were increased as reported in Figure 4.
DISCUSSION
In the present study we found decreased propor-
tions of CD4+CD25highFoxP3+ cells in induced spu-
tum of the bronchial asthmatic groups, particularly
in patients with moderate asthma, indicating low
numbers of Treg cells compared to healthy children.
We believe that using the combination of
CD4+CD25high with FoxP3 as a marker of Treg cells
will reflect more accurately the true numbers of
Treg cells in induced sputum from asthmatics. In
this study, the decreased proportions of
CD4+CD25highFoxP3+ cells in mild and moderate




























































































FIGURE 3: FAILURE TO SUPPRESS THE LPS-INDUCED PROINFLAMMATORY RESPONSE OF MONOCYTES/MACROPHAGES BY
TREG CELLS IN MODERATE BRONCHIAL ASTHMA 
Monocytes were cultured as described in the legend of Figure 2. After 40 h of co-culture, LPS (50 ng/ml) was added and 24 h later cytokine pro-
duction was measured by ELISA (IL-6, TNF-α) or Luminex (IL-1β). The average production of ten independent experiments ± SD of proinflam-
matory cytokines is shown for the three culture conditions. Significant differences are seen in the graphs between moderate asthmatic children
and healthy children. Moderate asthma = white bars; healthy controls = black bars.






























supported by low expression of FoxP3 mRNA in
CD3+ cells in the same patients. We also provide
evidence for a previously uncharacterized role of
human CD4+CD25+FoxP3+Treg cells, their ability to
steer differentiation of monocytes toward AAMs.
The expression of CD206, CD163 and CCL18 pro-
duction was increased in moderate asthmatics than
in healthy controls, when monocytes were co-cul-
tured with CD4+CD25+.
To confirm the concept that treatment with inhaled
corticosteroid could increase the frequency of
peripheral CD4+CD25high T cells, we compared the
quantitative change of this cell subset in 8 patients
with moderate asthma before and after 6 weeks of
inhaled corticosteroids. Although the increase after
the treatment was slight, it was statistically signifi-
cant. We speculate that dosage and course of the
treatment may influence the final results. Further
investigations are therefore needed to clarify this
issue in asthma. Recently Zhang et al. [16] reported
a slight increase of Treg cells after 4 weeks of
inhaled budesonide treatment, but the difference
observed before and after treatment was not statisti-
cally significant.
The frequency and phenotypic characteristics of
CD4+, FoxP3+ T cells as well as their capacity to
suppress inflammatory cytokine production and
proliferation of CD4+, CD25- T cells (target cells)
were comparable in young (age ≤ 40 years) and eld-
erly (age ≥ 65 years) individuals. However, when
CD4+, FoxP3+ Treg and CD4+, CD25-T cells were
co-cultured, the production of anti-inflammatory
cytokine IL-10 from CD4+, CD25- T cells was more
potently suppressed in the elderly than in the
young. This finding was not due to changes in cyto-
toxic T lymphocyte antigen (CTLA)-4 expression or
apoptosis of CD4+, FoxP3+ Treg and CD4+, CD25- T
cells. Taken together, these data [17] suggested that
aging may affect the capacity of CD4+, FoxP3+ T
cells to regulate IL-10 production from target CD4+
T cells in humans although their other cellular char-
acteristics remain unchanged. We can speculate
that no significant differences are observed between
young and adult asthmatics in their peripheral
blood circulation. However, no data were found
concerning values of Treg cells in adult induced
sputum. Homeostasis of Treg is controlled by sever-
al factors, among them the circulation and possibly
their redistribution to extra-vascular tissue [18]. We
can only speculate which factors contribute to
decreased percentages of Tregs in induced sputum
of asthmatics. 
The role of IL-10 and transforming growth factor
(TGF) has been suggested in the Treg-mediated reg-
ulation of T cell responses in vivo [19-20]. Treg cells
produce IL-10 or TGF-β or both, by which they
attain most of their suppressive activity. IL-10 pro-
duction suppresses exaggerated Th2 reactions. It
inhibits directly and indirectly the activity of mast
cells, basophils and eosinophils [21]. Peripheral
blood analysis in asthmatics failed to reveal modifi-
cation in absolute numbers of CD4+CD25+ T cells.
However, bronchoalveolar lavage fluid of asthmatic
children possessed significantly diminished levels
of CD4+CD25+ T cells, IL-10 and TGF-β mRNA
expression [22]. 
After administration of IL-2:anti-IL-2 complexes
before and after allergenic stimulation, a remark-
able increase in Treg counts was observed along






















FIGURE 4: CHANGES IN PROPORTIONS OF CD4+CD25HIGHFOXP3+ CELLS IN THE CD4+ CELL POPULATION FROM EIGHT
PATIENTS WITH MODERATE ASTHMA, BEFORE AND AFTER TREATMENT 
Eight patients received treatment with inhaled corticosteroid and were revisited after 6 weeks. Proportions of CD4+CD25highFoxP3+ cells in the
CD4+ cell population were slightly raised, and the difference between before (mean ± SD: 0.85 ± 0.43) and after (1.32 ± 0.63) treatment with
optimal inhaled corticosteroid reached a statistically significant level (p = 0.0035).
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tissue; in addition, subjects displayed decreased
pulmonary pathologic findings (mucus secretion,
airway inflammation and hyper-responsiveness
[23]. Recent data from Matsumoto et al. [24] raised
the possibility that lung CD4+CD25+FoxP3+ Treg
cells may regulate asthma phenotype. The frequen-
cy of CD4+CD25+FoxP3+ Treg cells among
CD4+CD25+ T cells in peripheral blood of asth -
matics and in murine asthma model was significant-
ly lower than that of healthy subjects [24].
Our data in asthmatics show that CD206, CD163
and CCL18 were increased compared to healthy
controls. These findings indicate that Treg-mediated
up-regulation of the macrophage mannose receptor
may involve a novel pathway that depends on cell
contact in controls and more so in asthmatics. Our
data in healthy controls were in accordance with
those reported by Tiemessen et al. [10]. Our data
suggest that CD4+CD25+ Treg cells from moderate
asthmatics exhibit a loss of suppression inducing
production of high levels of proinflammatory
cytokines (IL-1, IL-6 and TNF-α), contrasting with
data obtained in healthy controls. According to all
the reported data, we can speculate that the low
suppressive activity of Treg cells in moderate asth-
ma could be due in part to dysregulated cytokine
production [21]. 
AAM are cells with strong anti-inflammatory poten-
tial involved in immune regulation and tissue
remodeling [23]. Co-culture of Treg cells with
monocytes/macrophages displays typical features of
AAM, including up-regulated expression of CD206
(macrophage mannose receptor) and CD163
(hemoglobin scavenger receptor), an increased pro-
duction of CCL18, and an enhanced phagocytic
capacity. In addition, the monocytes/macrophages
have reduced expression of HLA-DR and a strongly
reduced capacity to respond to LPS in terms of
proinflammatory mediator production (IL-1β, IL-6,
IL-8, MIP-1α, TNF-α), nuclear factor (NF)-κB activa-
tion, and tyrosine phosphorylation [10,25].
Mechanistic studies reveal that CD4+CD25+FoxP3+
Tregs produce IL-10, IL-4, and IL-13 and that these
cytokines are the critical factors involved in the sup-
pression of the proinflammatory cytokine response
[10,25]. CD4+CD25+ Tregs down-regulate proin-
flammatory cytokine production (IFN-γ and TNF-α),
and directly inhibit IL-2 mRNA transcription. In
vitro, the mechanism behind T cell suppression
appears to be independent of IL-10 and TGF-β and
based on cell contact between Tregs and responder
T cells. Treg-mediated suppression in vivo involves
multicellular clusters consisting of responder T
cells, APC, and regulatory T cells, and during these
cellular interactions membrane-bound and/or solu-
ble inhibitory molecules contribute to suppression
[10,25].
The present study is, to our knowledge, the first
demonstration of decreased proportions of Treg
cells in induced sputum from mild and moderate
asthmatic children. Our findings in the present
study, showing markedly decreased proportions of
CD4+CD25highFoxP3+ cells in young asthmatic
patients, suggest that deficient immune regulation is
an early event in this pathology. However, further
studies are needed to clarify (i): how this Treg abnor-
mality contributes to asthma severity, (ii): the
strength correlation between monocytes/macrophages
and Treg cells, (iii): the production of IL-10 and
TGF-β by bronchial Treg cells. The role of T cells in
asthma is complex and probably tightly regulated
by the microenvironment.  
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